Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents

August 22, 2024 updated by: Beijing Normal University

Effectiveness of AI-powered Mobile Phone-based Interventions in Parental Smoking Cessation

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention tailored specifically for smoking parents.

Study Overview

Detailed Description

Parental smoking is associated with numerous adverse outcomes, including exposure to secondhand smoke, heightened risk of respiratory illnesses in children, and an increased likelihood that children will adopt smoking behaviors themselves. Despite awareness of these risks, many parents find it challenging to quit smoking due to stress, lack of support, and time constraints.

This randomized controlled trial (RCT) investigates the effectiveness of a mobile phone-based intervention tailored specifically for smoking parents. The intervention group will receive AI-powered chatbot cessation support, while the control group will be provided with brief cessation advice. The study aims to determine whether the AI-driven intervention is more effective in helping parents quit smoking compared to traditional brief advice.

Study Type

Interventional

Enrollment (Estimated)

300

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Guangdong
      • Zhuhai, Guangdong, China, 519087
        • Beijing Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. aged 18 and above, reside in Zhuhai for the next 6 months
  2. smoke at least 1 cigarette or use e-cigarettes daily
  3. have a smartphone and a WeChat account, able to use WeChat skillfully

Exclusion Criteria:

  1. Smokers who have communication barrier (either physically or cognitively)
  2. Smokers who are currently participating in other SC programmes or services

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AI chatbot support group
AI-powered chatbot support+ 5A's/5R's advice + health warning leaflet
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.
Participants will receive three months of AI-powered chatbot, equipped with personalized interactions and real-time support, via WeChat.
Active Comparator: Control group
5A's/5R's advice + health warning leaflet
5A's (Ask, Advise, Assess, Assist, Arrange) for smokers who are ready to quit, and 5R's (relevance, risks, rewards, roadblocks, and repetition) for smokers who are not ready to quit.
The health warning leaflet provides essential information on the dangers of secondhand and thirdhand smoke. It outlines how exposure to these forms of smoke can harm both smokers and non-smokers, particularly children, by increasing the risk of respiratory illnesses and other health issues.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported 7-day point prevalence quit rate
Time Frame: 3 and 6 months follow-up
Self-reported 7-day point prevalence quit rate in the two groups
3 and 6 months follow-up
Eligibility rate
Time Frame: baseline
the percentage of eligible smokers out of the total number of smokers screened
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Consent rate
Time Frame: baseline
the percentage of eligible smokers who agree to participate out of the total number of eligible smokers
baseline
Percentage of Participant Engagement with E-Messages and Counselor Chats
Time Frame: 3 months follow-up
This outcome measures the percentage of participants who engage with the intervention by reading e-messages and responding to counselor chat messages at least once during the 3-month follow-up period.
3 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

June 20, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

August 16, 2024

First Submitted That Met QC Criteria

August 22, 2024

First Posted (Actual)

August 26, 2024

Study Record Updates

Last Update Posted (Actual)

August 26, 2024

Last Update Submitted That Met QC Criteria

August 22, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • mCessation in smoking parents

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on 5A's/5R's advice

Subscribe